Harmony
Payments companies reported to CMS as associated with Harmony. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Harmony, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Harmony
These are the largest totals companies reported as associated with Harmony. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Matthew Gillespie | Philadelphia, PA | Pediatric Cardiology | $656,594.81 |
| John Cheatham | Columbus, OH | Interventional Cardiology | $532,951.61 |
| Doff Mcelhinney | Palo Alto, CA | Pediatric Cardiology | $520,518.30 |
| Bryan Goldstein | Pittsburgh, PA | Pediatric Cardiology | $363,648.58 |
| Thomas Jones | Seattle, WA | Pediatric Cardiology | $303,123.11 |
| Jeffrey Zampi | Ann Arbor, MI | Pediatric Cardiology | $276,518.43 |
| Athar Qureshi | Cleveland, OH | Pediatric Cardiology | $186,537.89 |
| Joseph Paolillo | Charlotte, NC | Pediatric Cardiology | $135,153.14 |
| Osamah Aldoss | Milwaukee, WI | Pediatric Cardiology | $94,736.04 |
| Zachary Steinberg | Seattle, WA | Adult Congenital Heart Disease | $88,781.43 |
Prescribed Harmony?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.